Key Highlights

  • Third quarter Revenue of USD 55.5 million compares with a USD 53.70 million estimate and USD 74.9 million last year.
  • GAAP diluted EPS was USD 1.41 against a USD 0.47 loss estimate; adjusted EPS was a USD 0.46 loss.
  • Backlog stood at USD 7.0 billion, including USD 5.4 billion in contingent uranium enrichment sales commitments.
  • Cash was USD 2,236.1 million, and full-year 2026 revenue is guided to USD 450 million to USD 500 million.

Centrus Energy Corp. (NYSE:LEU) reported third quarter 2026 revenue of USD 55.5 million, against an estimate of USD 53.70 million and USD 74.9 million in the third quarter of 2025. Net Income was USD 31.6 million, or USD 1.41 per diluted share, compared with USD 3.9 million, or USD 0.19, a year earlier. The company also reported an adjusted net loss of USD 9.4 million, or an adjusted loss of USD 0.46 per share.

Revenue by Line

Total revenue was USD 55.5 million, a decrease of 26% from the prior year. Low-enriched uranium segment revenue was USD 31.8 million against USD 44.8 million, with uranium revenue lower on a smaller Volume sold. Separative work unit revenue rose, reflecting a 19% increase in volume sold and a 10% increase in the average price.

Technical Solutions revenue was USD 23.7 million against USD 30.1 million. The company attributed USD 10.2 million of the decrease to a 2022 HALEU production contract.

Profit and Margins

Gross loss was USD 10.6 million, compared with USD 4.3 million a year earlier. Gross loss for the low-enriched uranium segment was USD 6.9 million against USD 7.8 million, and the company noted that its customers generally hold multi-year contracts with annual rather than quarterly purchase commitments, so gross loss varies with contract timing. Technical Solutions recorded a gross loss of USD 3.7 million against a profit of USD 3.5 million.

Operating loss was USD 29.7 million against USD 16.6 million. Net income included a USD 46.4 million gain from the Fair Value adjustment of Warrant liabilities. Selling, general and administrative expense was USD 13.2 million against USD 9.5 million.

Cash, Debt and Backlog

Cash and cash equivalents were USD 2,236.1 million at September 30, against USD 1,957.2 million at December 31, 2025. Long-term debt was USD 1,178.8 million.

Backlog across both segments was USD 7.0 billion, extending to 2040. The low-enriched uranium segment Backlog was approximately USD 6.2 billion, including approximately USD 5.4 billion in contingent sales commitments for low-enriched and high-assay uranium, of which USD 5.1 billion are under definitive agreements. Technical Solutions backlog was approximately USD 0.8 billion. The company said the proposed federal fiscal 2027 budget contains no further funding for operating the HALEU cascade.

2026 Guidance and Operating Milestones

For full-year 2026, the company is guided to total revenue of USD 450 million to USD 500 million and total Capital deployment of USD 350 million to USD 500 million, driven by centrifuge Manufacturing investment. It also targets at least 100 net new hires at Oak Ridge, Tennessee, and at least 175 at Piketon, Ohio, up from an earlier target of 100.

CEO Amir Vexler said the company shipped its first new centrifuge from Oak Ridge about two months ahead of its own schedule and that its Supply chain is unobligated. The company also finalized contracts with all supply chain parties it deemed critical and completed its first certified-for-construction package, each ahead of its year-end target.

Numbers in Context

Third quarter revenue of USD 55.5 million sits alongside GAAP diluted EPS of USD 1.41, an adjusted EPS loss of USD 0.46 and cash of USD 2,236.1 million. The USD 7.0 billion backlog sits next to full-year revenue guidance of USD 450 million to USD 500 million.

Management named the scale-up of supply chain and centrifuge shipments from Oak Ridge to Piketon, along with the Westerman acquisition, as its focus.